Michelle Bell

After 65 years, Generac is a finalist for Wisconsin's top manufacturing award, lauded for its tech innovation, economic impact, and community investment.

The Collegiate Cup is set as 12 universities head to Florida for the national championship, showcasing future stars and the rapid growth of cricket in America.

The suburban office REIT has extended key debt maturities and lowered borrowing costs, signaling lender confidence and positioning it for strategic growth.

Alta is set to reveal its full-year 2025 results after a year of strategic pivots. Investors will watch for signs of recovery and strategic progress.

vivo's new V70 challenges the premium market with a powerful ZEISS telephoto lens, a massive battery, robust IP69 rating, and a long-term software promise.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

With $3.7M in new capital, Sift Biosciences is developing a novel immunotherapy to awaken the body's memory T cells against hard-to-treat diseases.

Canary Capital's SUIS fund on Nasdaq offers investors SUI exposure plus staking rewards, entering a market with immediate competition and notable risks.

A major refinancing deal in Florida and Texas signals a Wall Street rush into senior living, a sector fueled by an aging population and tight supply.

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

USANA posts higher 2025 sales fueled by its Hiya and Rise brands, but a Q4 loss and a shrinking core business reveal the high cost of its transformation.

SRTX Inc., maker of 'unbreakable' Sheertex hosiery, files for creditor protection and sells assets to a rival. Can the innovative brand survive?

A new report reveals a major shift in digital strategy. Businesses are now betting big on AI to boost internal productivity, even as costs and complexity soar.

A landmark gigawatt-scale agreement for US-made steel solar frames signals a major shift in domestic supply chains and next-generation module durability.

Investors eye Paratus Energy’s Q4 results for updates on its Mexican rig contracts and payment cycles, contrasting with its strong Brazilian subsea performance.

The veteran-founded coffee brand is on the clock after its stock price fell below $1.00, triggering a six-month window to brew a market turnaround.

RBC Global Asset Management is overhauling its fund lineup, shifting to quantitative strategies and merging funds. Here’s what it means for investors.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

The Canadian restaurant giant defied a tough market in 2025, posting record sales and boosting investor payouts through strategic promotions and delivery.

Appili Therapeutics lands a $40M deal to fight fungal threats, but with cash reserves low and loans due, can its science outpace its financial pressures?